alanine has been researched along with gsk299423 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anderluh, M; Burton, NP; Germe, T; Hrast, M; Kolarič, A; Lawson, DM; Maxwell, A; Minovski, N; Stevenson, CEM; Vörös, J | 1 |
1 other study(ies) available for alanine and gsk299423
Article | Year |
---|---|
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds.
Topics: Alanine; Anti-Bacterial Agents; Chlorine; Crystallography, X-Ray; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Single-Stranded; Drug Design; ERG1 Potassium Channel; Escherichia coli; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Docking Simulation; Poly-ADP-Ribose Binding Proteins; Quinolines; Staphylococcus aureus; Topoisomerase II Inhibitors | 2021 |